rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences
Chantal Sellier(Centre National de la Recherche Scientifique), Nicolas Charlet‐Berguerand(Institut de génétique et de biologie moléculaire et cellulaire), Jack Puymirat(Université Laval), Benedikt Schoser(Friedrich Baur Stiftung), Partha S. Sarkar(Institute of Neurobiology), Markus Blatter(ETH Zurich), G. Meola(IRCCS Policlinico San Donato), Beatriz Llamusí(SOM Biotech (Spain)), Frank Ruffenach(Centre National de la Recherche Scientifique), Fernande Freyermuth(Broad Institute), Denis Furling(Cytoskeleton (United States)), Estefanía Cerro-Herreros(Universitat de València), Bjarne Udd(Folkhälsans Forskningscentrum), Masanori Takahashi(Sapporo Medical University), Rubén Artero(Universitat de València), Frédéric H.‐T. Allain(ETH Zurich), Guillaume Bassez(Centre Hospitalier Universitaire Henri-Mondor), Harutoshi Fujimura(Toneyama National Hospital), Angéline Gaucherot(Centre National de la Recherche Scientifique)
Cited by 77
Related Papers
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
|The Lancet Neurology|2012|487
Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains
|Cell|2018|487
Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin
|The American Journal of Human Genetics|2002|484
Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle
|Journal of Clinical Investigation|2004|365